Martin Bachmann to Humans
This is a "connection" page, showing publications Martin Bachmann has written about Humans.
Connection Strength
0.096
-
In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy. 2022 01; 77(1):111-117.
Score: 0.008
-
Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction. Allergy. 2022 01; 77(1):143-149.
Score: 0.008
-
BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced. Allergy. 2021 09; 76(9):2895-2998.
Score: 0.008
-
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection. Int Arch Allergy Immunol. 2020; 181(8):624-628.
Score: 0.007
-
Immunogenicity and Immunodominance in Antibody Responses. Curr Top Microbiol Immunol. 2020; 428:89-102.
Score: 0.007
-
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects. J Allergy Clin Immunol. 2019 07; 144(1):193-203.
Score: 0.007
-
RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion. Front Immunol. 2019; 10:736.
Score: 0.007
-
A vaccine against Alzheimer`s disease: anything left but faith? Expert Opin Biol Ther. 2019 01; 19(1):73-78.
Score: 0.006
-
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference. Expert Rev Vaccines. 2019 01; 18(1):1-3.
Score: 0.006
-
Biosensor-based selective detection of Zika virus specific antibodies in infected individuals. Biosens Bioelectron. 2018 Aug 15; 113:101-107.
Score: 0.006
-
Major findings and recent advances in virus-like particle (VLP)-based vaccines. Semin Immunol. 2017 12; 34:123-132.
Score: 0.006
-
Isolation of human monoclonal antibodies by mammalian cell display. Proc Natl Acad Sci U S A. 2008 Sep 23; 105(38):14336-41.
Score: 0.003
-
Therapeutic vaccination for chronic diseases: a new class of drugs in sight. Nat Rev Drug Discov. 2004 Jan; 3(1):81-8.
Score: 0.002
-
von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019. Crit Care Med. 2021 05 01; 49(5):e512-e520.
Score: 0.002
-
Anasthesiol Intensivmed Notfallmed Schmerzther. 2021 04; 56(4):277-287.
Score: 0.002
-
Universities of Applied Sciences. Chimia (Aarau). 2021 Mar 31; 75(3):215-218.
Score: 0.002
-
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study. Allergy. 2021 03; 76(3):853-865.
Score: 0.002
-
Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany. Aust Crit Care. 2021 Mar; 34(2):167-175.
Score: 0.002
-
[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2020 Apr; 55(4):257-265.
Score: 0.002
-
A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation. J Allergy Clin Immunol. 2018 08; 142(2):557-568.e6.
Score: 0.001
-
Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis. PLoS One. 2017; 12(5):e0177964.
Score: 0.001
-
Detecting circulating antibodies by controlled surface modification with specific target proteins: Application to malaria. Biosens Bioelectron. 2017 May 15; 91:833-841.
Score: 0.001